Catalyst
Slingshot members are tracking this event:
European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Approval of Sanofi's (SNY) Suliqua in Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SNY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Medicines Agency, Chmp, Positive Opinion, Suliqua, Ecommending Approval, Type 2 Diabetes
